Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

- Cunningham, Evan B., Amin, Janaki, Dunlop, Adrian J., Norton, Briana, Litwin, Alain H., Hajarizadeh, Behzad, Thurnheer, Maria Christine, Dillon, John F., Weltman, Martin, Shaw, David, Bruggmann, Philip, Gane, Edward, Feld, Jordan J., Fraser, C, Marks, P, Applegate, TL, Quiene, S, Siriragavan, S, Matthews, GV, Dore, GJ, Grebely, J, Bruneau, Julie, Dalgard, Olav, Powis, Jeff, Hellard, Margaret, Cooper, Curtis, Read, Phillip, Conway, Brian

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

- Cunningham, Evan B., Hajarizadeh, Behzad, Swan, Tracy, Marks, Philippa S., Quiene, Sophie, Applegate, Tanya L., Weltman, Martin, Shaw, David, Dunlop, Adrian, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Dalgard, Olav, Thurnheer, Maria Christine, Dore, Gregory J., Grebely, Jason, Amin, Janaki, Hellard, Margaret, Foster, Graham R., Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert